| Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes P Valent, AD Klion, HP Horny, F Roufosse, J Gotlib, PF Weller, ... Journal of Allergy and Clinical Immunology 130 (3), 607-612. e9, 2012 | 826 | 2012 |
| Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy PU Ogbogu, BS Bochner, JH Butterfield, GJ Gleich, J Huss-Marp, JE Kahn, ... Journal of Allergy and Clinical Immunology 124 (6), 1319-1325. e3, 2009 | 667 | 2009 |
| Treatment of patients with the hypereosinophilic syndrome with mepolizumab ME Rothenberg, AD Klion, FE Roufosse, JE Kahn, PF Weller, HU Simon, ... New England Journal of Medicine 358 (12), 1215-1228, 2008 | 664 | 2008 |
| Refining the definition of hypereosinophilic syndrome HU Simon, ME Rothenberg, BS Bochner, PF Weller, AJ Wardlaw, ... Journal of allergy and clinical immunology 126 (1), 45-49, 2010 | 373 | 2010 |
| Practical approach to the patient with hypereosinophilia F Roufosse, PF Weller Journal of Allergy and Clinical Immunology 126 (1), 39-44, 2010 | 355 | 2010 |
| Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias P Vandenberghe, I Wlodarska, L Michaux, P Zachée, M Boogaerts, ... Leukemia 18 (4), 734-742, 2004 | 245 | 2004 |
| Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes FE Roufosse, JE Kahn, GJ Gleich, LB Schwartz, AD Singh, ... Journal of allergy and clinical immunology 131 (2), 461-467. e5, 2013 | 230 | 2013 |
| Hypereosinophilic syndromes FE Roufosse, M Goldman, E Cogan Orphanet journal of rare diseases 2, 1-12, 2007 | 228 | 2007 |
| Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome F Roufosse, L Schandené, C Sibille, K Willard‐Gallo, B Kennes, A Efira, ... British journal of haematology 109 (3), 540-548, 2000 | 215 | 2000 |
| Recent advances in pathogenesis and management of hypereosinophilic syndromes F Roufosse, E Cogan, M Goldman Allergy 59 (7), 673-689, 2004 | 200 | 2004 |
| Lymphocytic variant hypereosinophilic syndromes F Roufosse, E Cogan, M Goldman Immunology and allergy clinics of North America 27 (3), 389-413, 2007 | 182 | 2007 |
| Novel targeted therapies for eosinophilic disorders ME Wechsler, PC Fulkerson, BS Bochner, GM Gauvreau, GJ Gleich, ... Journal of allergy and clinical immunology 130 (3), 563-571, 2012 | 181 | 2012 |
| The hypereosinophilic syndrome revisited F Roufosse, E Cogan, M Goldman Annual Review of medicine 54 (1), 169-184, 2003 | 181 | 2003 |
| Targeting the interleukin-5 pathway for treatment of eosinophilic conditions other than asthma F Roufosse frontiers in Medicine 5, 49, 2018 | 177 | 2018 |
| Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field P Valent, GJ Gleich, A Reiter, F Roufosse, PF Weller, A Hellmann, ... Expert review of hematology 5 (2), 157-176, 2012 | 176 | 2012 |
| Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial F Roufosse, JE Kahn, ME Rothenberg, AJ Wardlaw, AD Klion, SY Kirby, ... Journal of Allergy and Clinical Immunology 146 (6), 1397-1405, 2020 | 137 | 2020 |
| Sustained response to mepolizumab in refractory Churg-Strauss syndrome JE Kahn, C Grandpeix-Guyodo, I Marroun, E Catherinot, F Mellot, ... Journal of allergy and clinical immunology 125 (1), 267-270, 2010 | 132 | 2010 |
| Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome F Roufosse, A De Lavareille, L Schandené, E Cogan, A Georgelas, ... Journal of allergy and clinical immunology 126 (4), 828-835. e3, 2010 | 117 | 2010 |
| High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome A De Lavareille, F Roufosse, P Schmid-Grendelmeier, AS Roumier, ... Journal of allergy and clinical immunology 110 (3), 476-479, 2002 | 99 | 2002 |
| Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Y Nguyen, L Guillevin Seminars in Respiratory and Critical Care Medicine 39 (04), 471-481, 2018 | 90 | 2018 |
